InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by JAMES MULAY. Director active across 2 companies, notably CG ONCOLOGY INC. Aggregated, 2 filings have been recorded. Activity tracked since 1 July 2026. The latest transaction was disclosed on 10 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations